blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1891036

EP1891036 - ALPHA 7 NICOTINIC RECEPTOR SELECTIVE LIGANDS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  13.01.2017
Database last updated on 15.06.2024
Most recent event   Tooltip13.01.2017Application deemed to be withdrawnpublished on 15.02.2017  [2017/07]
Applicant(s)For all designated states
University of Florida Research Foundation, Inc.
P.O. Box 115500 Gainesville
Florida 32611-5500 / US
[2008/09]
Inventor(s)01 / KEM, William, R.
1809 Nw 47th Street
Gainesville, FL 32605-3454 / US
02 / SOTI, Ferenc
708 S.W. 16th Ave., Apt. 207
Gainvesville, FL 32601-8521 / US
 [2008/09]
Representative(s)Zacco Denmark A/S
Arne Jacobsens Allé 15
2300 Copenhagen S / DK
[N/P]
Former [2013/03]Zacco Denmark A/S
Hans Bekkevolds Allé 7
2900 Hellerup / DK
Former [2008/09]Johansen, Marianne
Albihns A/S, H.C. Andersens Boulevard 49
1553 Copenhagen V / DK
Application number, filing date06772438.507.06.2006
[2008/09]
WO2006US22136
Priority number, dateUS20050688216P07.06.2005         Original published format: US 688216 P
[2008/09]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2006133303
Date:14.12.2006
Language:EN
[2006/50]
Type: A1 Application with search report 
No.:EP1891036
Date:27.02.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 14.12.2006 takes the place of the publication of the European patent application.
[2008/09]
Search report(s)International search report - published on:US14.12.2006
(Supplementary) European search report - dispatched on:EP05.07.2010
ClassificationIPC:C07D401/02, A61K31/44
[2008/09]
CPC:
C07D401/04 (EP,US); A61P25/00 (EP); A61P25/16 (EP);
A61P25/18 (EP); A61P25/28 (EP); A61P25/30 (EP);
A61P29/00 (EP); A61P35/00 (EP); A61P9/00 (EP);
C07D401/14 (EP,US); C07D405/14 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/09]
Extension statesRSNot yet paid
TitleGerman:SELEKTIVE LIGANDEN FÜR ALPHA-7-NIKOTINREZEPTOREN[2008/09]
English:ALPHA 7 NICOTINIC RECEPTOR SELECTIVE LIGANDS[2008/09]
French:LIGANDS SÉLECTIFS DU RÉCEPTEUR NICOTINIQUE ALPHA 7[2008/09]
Entry into regional phase07.01.2008National basic fee paid 
07.01.2008Search fee paid 
07.01.2008Designation fee(s) paid 
07.01.2008Examination fee paid 
Examination procedure07.01.2008Examination requested  [2008/09]
07.06.2011Amendment by applicant (claims and/or description)
19.02.2013Despatch of a communication from the examining division (Time limit: M06)
02.09.2013Reply to a communication from the examining division
18.11.2014Despatch of a communication from the examining division (Time limit: M06)
22.05.2015Reply to a communication from the examining division
04.05.2016Despatch of a communication from the examining division (Time limit: M04)
15.09.2016Application deemed to be withdrawn, date of legal effect  [2017/07]
11.10.2016Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2017/07]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  19.02.2013
Request for further processing for:The application is deemed to be withdrawn due to failure to indicate the wish to proceed further with the application
07.06.2011Request for further processing filed
07.06.2011Full payment received (date of receipt of payment)
Request granted
28.07.2011Decision despatched
The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
07.06.2011Request for further processing filed
07.06.2011Full payment received (date of receipt of payment)
Request granted
28.07.2011Decision despatched
Fees paidRenewal fee
30.06.2008Renewal fee patent year 03
30.06.2009Renewal fee patent year 04
11.06.2010Renewal fee patent year 05
27.06.2011Renewal fee patent year 06
26.06.2012Renewal fee patent year 07
27.06.2013Renewal fee patent year 08
30.06.2014Renewal fee patent year 09
29.06.2015Renewal fee patent year 10
Penalty fee
Additional fee for renewal fee
30.06.201611   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]US5977144  (MEYER EDWIN M [US], et al) [A] 1-49* column 40; claim 1 *;
 [XDI]WO2004019943  (MEMORY PHARM CORP [US], et al) [XD] 11-13,29-34,40,49 * page 13 - line 16 * * page 45 - lines 9-17 * * page 131; claim 1 * [I] 1-10,14-28,35-39,41-48;
 [I]  - DE FIEBRE ET AL, "Characterization of a series of anabaseine-derived compounds reveals that the 3-(4)-dimethylaminocinnamylidine derivative is a selective agonist at neuronal nicotinic.alpha.7/125I-.alpha.-bungarotoxin receptor subtypes", MOLECULAR PHARMACOLOGY, AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, US, (19950101), vol. 47, no. 1, ISSN 0026-895X, pages 164 - 171, XP002088634 [I] 1-49 * page 164 * * page 165; figure 1; compounds DMXB, DMAB, DMAC *
International search[A]US5977144  (MEYER EDWIN M [US], et al);
 [A]  - ARENDASH G.W., "Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21", BRAIN RESEARCH, (1995), vol. 674, no. 2, pages 252 - 259, XP003000691

DOI:   http://dx.doi.org/10.1016/0006-8993(94)01449-R
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.